Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2029

Conditions

Ovarian Cancer

Interventions

DRUG

fluzopanib and bevacizumab

fluzopanib and bevacizumab were used for maintenance treatment

Trial Locations (1)

RECRUITING

Chongqing Cancer Hospital, Chongqing

All Listed Sponsors

lead

Chongqing University Cancer Hospital

OTHER